OBGYN & Women's Health

Texas judge alleges that the FDA should not have approved mifepristone because it did not adequately review its safety risks

Pooled incidence 1.7 and 12.1 per 100 person-years for HIV, hepatitis C, respectively, with higher risk seen in the young and in women

Two opposing rulings are setting the stage for a Supreme Court showdown on the safety of mifepristone

Risk-stratified timing of birth at 35 to 36 weeks of gestation would result in 57.2 percent preeclampsia prevention

Mortality rates did not change significantly for infants of Black, Hispanic teens within rural counties

BMI associated with wound healing greater than two months; age associated with minor complications

Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine

Method identifies greatest proportion of adults with prediabetes and diabetes compared with USPSTF recommendations and BMI-based screening

Evidence stronger for link to cardiometabolic outcomes based on 73 existing meta-analyses

Proportion of undiagnosed breech presentations at term decreased with routine third-trimester ultrasound or point-of-care ultrasound